Optional increase dosage: 1.0 mg for at least 4 weeks 2.0 mg a week (This is the current maximum dose for Ozempic) Eapen, MD, says, The decision to increase beyond 0.5 mg depends on your individual needs, how well you tolerate the medication, and your treatment goals
National Library of Medicine , "FDA Approves Ozempic (Semaglutide) as the Only GLP-1 RA to Reduce the Risk of Worsening Kidney Disease and Cardiovascular Death in Adults with Type 2 Diabetes and Chronic Kidney Disease." PR Newswire , "FDA Approves Wegovy (Semaglutide) for Adults with Obesity." Drugs.com , 2021, Fonseca, Vivian A., et al
During the acute painful phase, a minority of patients have symptoms of hyperthyroidism (diaphoresis, palpitations, and tremor) lasting several weeks
\n\n\n\n 3
To help lose menopause-related weight, some women are turning to GLP-1 medications